Pfizer Partners with China Resources for Operations of Four Oncology Drugs in China!
On November 26, 2024, Pfizer announced a strategic cooperation with China Resources Pharmaceutical Commercial to manage the commercialization of four oncology treatments in China. These medications include Anastrozole, Abiraterone, Palbociclib, and Crizotinib, which will be managed by China Resources. Pfizer’s China President, Peng Zhenke, and China Resources’ Deputy General Manager, Han Yuewei, attended the signing ceremony. Among these drugs, Icotinib and Epirubicin have already been included in the alliance procurement list, while Palbociclib and Crizotinib are subject to national negotiations, resulting in significant price reductions. Palbociclib also appeared in the newly published tenth national procurement list, indicating further price cuts. The collaboration will commence on December 1, with Pfizer working closely with China Resources to ensure a smooth transition for affected employees.
You May Interested In
2026-09-29
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Geopolitical Conflict Drives Up Chemical Costs: The Industry Signal Behind DuPont’s Upgraded Outlook
-
Supply Chain Resilience Reshapes Chemical Competition: What Lies Behind BASF’s Stable Outlook
-
AstraZeneca’s Wainua Fails Phase III Heart Trial, Wiping Out About $27 Billion in Market Value
-
Covestro Unveils TPU Application Development Hub in Guangzhou, Strengthening Regional Innovation Network
-
BASF Technology with CFRP Lands in Nanjing: High-Performance Dispersant Production Line Officially Commissioned
-
China’s Polyolefin Exports Keep Surging, Reversing the Global Plastics Trade Map
-
China Eases July Fuel Export Curbs as Zhejiang Petrochemical Resumes Shipments
-
Nippon Paint Offers $8.55 Billion for AkzoNobel’s Decorative Paints Business
-
Typhoon Bavi Hits Zhejiang and Fujian, Putting Two Major Petrochemical Hubs at Logistics Risk
-
UK AGC Plans to Close PFAS Plant as Pressure on Europe’s Fluorochemicals Sector Intensifies
Recommend Reading
-
![BASF Opens Up PolyTHF® Technology: A Quiet but Powerful Shake-Up in the Global Fibers Game]()
BASF Opens Up PolyTHF® Technology: A Quiet but Powerful Shake-Up in the Global Fibers Game
-
![A $25 Billion “Mega Merger” Is Born: How the AkzoNobel × Axalta Deal Rewrites Global Coatings Power]()
A $25 Billion “Mega Merger” Is Born: How the AkzoNobel × Axalta Deal Rewrites Global Coatings Power
-
![April Chemical Industry Shutdown Wave Arrives: Maintenance Plans Reflect Deep Cost Anxiety Across Enterprises]()
April Chemical Industry Shutdown Wave Arrives: Maintenance Plans Reflect Deep Cost Anxiety Across Enterprises
-
![BASF and Clariant Exit Quietly! Behind Henkel’s High-Priced Acquisition, Why Did Former Allies Choose to “Let Go”?]()
BASF and Clariant Exit Quietly! Behind Henkel’s High-Priced Acquisition, Why Did Former Allies Choose to “Let Go”?
-
![Evonik Inaugurates New Speciality Alumina Plant in Japan, Bolstering Regional Growth Strategy]()
Evonik Inaugurates New Speciality Alumina Plant in Japan, Bolstering Regional Growth Strategy
-
![This week, caustic soda prices were weak (2.2-2.6)]()
This week, caustic soda prices were weak (2.2-2.6)
-
![This Week's Pure Benzene Market Prices Show Slight Fluctuations (2.2-2.6)]()
This Week's Pure Benzene Market Prices Show Slight Fluctuations (2.2-2.6)
-
![High Costs and Supply Contraction Keep Dichloromethane Prices Relatively Strong]()
High Costs and Supply Contraction Keep Dichloromethane Prices Relatively Strong
-
![This week (2026.2.2-2.6) polyester bottle chips first plummeted then stabilized in China]()
This week (2026.2.2-2.6) polyester bottle chips first plummeted then stabilized in China
-
![This Week's PVC Market Rises and Then Falls (2.2-2.6)]()
This Week's PVC Market Rises and Then Falls (2.2-2.6)
